ABT250110P119000
- 0.00
- 0.000.00%
Abbott Laboratories Newsroom
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Cuts Target Price to $136
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
8 Health Care Stocks Whale Activity In Today's Session
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $138
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT)
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy?
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt